Medical Amino Acid Market Expansion Outlook: $5.57 Billion in 2029

Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.

What Is the Projected CAGR for the Medical Amino Acid Market from 2024 to 2025?
The medical amino acid industry has witnessed substantial growth in the past few years. The market is projected to expand from $3.80 billion in 2024 to $4.11 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. The historical growth of the market can be credited to the rise in chronic diseases, increased instances of metabolic disorders, growing elderly population requiring specific nutritional care, heightened demand for parenteral nutrition solutions, and an increase in gastrointestinal disorder cases.

What are the Expected Market Size and CAGR for Medical Amino Acid by 2029?
The market size of medical amino acids is predicted to witness significant growth in the near future. It is anticipated to rise to $5.57 billion in 2029, boasting a compound annual growth rate (CAGR) of 7.9%. The surge during the forecast period is mainly due to increasing applications in treating liver ailments, usage in nutritional therapies for trauma and surgical patients, improved detection of amino-acid-related deficiencies, growing employments in muscle atrophy disease control, and rising needs for neonatal and pediatric nutrition. The forecast period is also expected to experience key trends such as advancements in amino acid synthesis technology, the creation of specialty amino acid mixtures, breakthroughs in amino acid-infused therapeutic foods, improved delivery systems, and enhancements in shelf-stability and bioavailability.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/medical-amino-acid-global-market-report

Which Factors Are Driving the Global Medical Amino Acid Market Expansion?
The medical amino acid market's growth is predicted to be fueled by the escalating occurrences of liver diseases. The term "liver disease" encompasses a variety of conditions that adversely impact the liver, interfering with its critical functions within the body. Rising obesity levels contribute to the surge in liver diseases, as they result in non-alcoholic fatty liver disease due to excessive fat buildup in liver cells, which hinders their capacity to function. Medical amino acids play a significant role in managing metabolic irregularities related to liver disease and support the regeneration of liver cells, making them vital in the nutritional therapy for affected individuals. The British Liver Trust, a charity based in the UK, reported a significant increase of 22.0% in primary hospital admissions due to liver disease in the fiscal year ending 2022. These cases jumped from 67,458 in 2021 to 82,290 in 2022. This accelerating rate of liver diseases is, therefore, steering the progress of the medical amino acid market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25819&type=smp

Which Segment Currently Holds the Largest Share of the Medical Amino Acid Market?
The medical amino acid market covered in this report is segmented -

1) Product Type: L-Glutamine, L-Arginine, L-Lysine, L-Leucine, L-Isoleucine, L-Valine, Other Product Types
2) By Application: Medical Supplements, Medicinal Foods, Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, Cell Culture Ingredients
3) By End-User: Hospitals, Research Laboratories, Clinics, Pharmaceutical Companies, Nutraceutical Companies

Subsegments:
1) By L-Glutamine: Powder Form, Capsule Form, Injectable Form
2) By L-Arginine: Oral Solution, Tablets, Intravenous Injection
3) By L-Lysine: Hydrochloride Form, Acetate Form, Supplement Blends
4) By L-Leucine: Branched-Chain Form, Micronized Powder, Pharmaceutical Grade
5) By L-Isoleucine: Isolated Form, Blended BCAA Form, Medical Nutrition Formulas
6) By L-Valine: Standalone Supplement, BCAA Combination, Clinical Nutrition Use
7) By Others Product Types: L-Tryptophan, L-Carnitine, L-Threonine, L-Histidine, Specialty Amino Acids

Which Major Trends Are Shaping the Future of the Medical Amino Acid Industry?
Focusing on the design and creation of advanced solutions, such as specialty amino acid-based formulas, is a priority for key corporations functioning in the medical amino acid market. These formulas are meant to cater to the nutritional needs of people with specific metabolic or absorption disorder, and can help lower the risk of allergic responses. For instance, Abbott, a renowned healthcare and medical devices enterprise from the United States, introduced EleCare - a specialty amino acid-based formula, in May 2022. Created as a hypoallergenic formula, EleCare is best suited for infants and children who suffer from severe food allergies or digestive problems, necessitating the need for nutrition from amino acids. It provides all essential nutrients necessary for their growth and development from infancy upto the age of 12 months. The formula proves beneficial for people who cannot consume or partially digest proteins, including individuals experiencing malabsorption, protein maldigestion, eosinophilic GI disorders, and short bowel syndrome. EleCare can be orally consumed or administered via a feeding tube under the supervision of a medical professional.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25819&type=smp

Which Key Players Dominate the Medical Amino Acid Industry Globally?
Major companies operating in the medical amino acid market are Cargill Inc., Archer Daniels Midland, Evonik Industries AG, Ajinomoto Co. Inc., Nippon Kayaku Co. Ltd., Kemin Industries Inc., Global Bio-Chem Technology Group Company Ltd., FUJIFILM Irvine Scientific, Nippon Rika Co. Ltd., Acuro Organica Limited, Ava Chemicals Pvt. Ltd., Kyowa Hakko Bio Co. Ltd., Wenda Co. Ltd., Catapharma Chemicals Pvt. Ltd., Chaitanya Group, Aelicure Pharma, KD Chem Pharma, Hexon Laboratories Pvt. Ltd., A B Enterprises, Shanghai Kyowa Amino Acid Co. Ltd.

What Are the Fastest-Growing Regions in the Medical Amino Acid Market?
North America was the largest region in the medical amino acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical amino acid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.